Tumor Suppressor Gene Therapy
The preceding chapters in these two volumes on tumor suppressor genes (TSG) are a comprehensive compilation of what is currently known about the structure, function, activation, and regulation of TSGs, along with the roles they play in the myriad biochemical pathways that network to result in living cells. With recent developments in molecular genetics, new information is revealed daily, and it is likely that we have only scratched the surface of the base of knowledge about TSGs that will soon be available. Even so, the studies reported thus far have already led to the identification of genetic alterations in TSGs that are responsible, in whole or in part, for cancer, and subsequently to the development and implementation of formidable therapeutic strategies.
- Phase I Clinical Trial of Locoregional Administration of the Oncolytic Adenovirus ONYX-015 in Combination with Mitomycin-C, Doxo
- Gene Therapy for Antitumor Vaccination
- Immunological and Gene Therapy for Ovarian Cancer A Technical Overview
- Proteomics and Cancer Epidemiology
- Gene Transfer into the Colonic Mucosa
- Introduction to the Analysis of the Human G-Banded Karyotype
- Transgenic Mouse Models for Prostate Cancer: Identification of an Androgen-Dependent Promoter and Creation and Characterization
- Chromogenic In Situ Hybridization in Tumor Pathology
- Antibody Targeting of Nanoparticles to Tumor-Specific Receptors: Immunoliposomes
- 免疫磁珠分選的問題